Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,110
Closed -$1.25M 69
2024
Q2
$1.25M Buy
10,110
+454
+5% +$58.5K 0.04% 46
2024
Q1
$1.27M Buy
9,656
+645
+7% +$79.5K 0.03% 45
2023
Q4
$982K Buy
9,011
+204
+2% +$21.2K 0.03% 44
2023
Q3
$907K Buy
8,807
+306
+4% +$33K 0.03% 43
2023
Q2
$981K Buy
8,501
+528
+7% +$60K 0.03% 44
2023
Q1
$848K Sell
7,973
-5,186
-39% -$560K 0.03% 44
2022
Q4
$1.46M Sell
13,159
-64
-0.5% -$6.54K 0.05% 33
2022
Q3
$1.14M Sell
13,223
-369
-3% -$32.9K 0.04% 35
2022
Q2
$1.24M Sell
13,592
-513
-4% -$45.5K 0.04% 33
2022
Q1
$1.16M Buy
14,105
+1,934
+16% +$152K 0.03% 38
2021
Q4
$933K Buy
12,171
+5,365
+79% +$427K 0.03% 44
2021
Q3
$511K Buy
6,806
+1,149
+20% +$87.4K 0.02% 47
2021
Q2
$440K Buy
5,657
+651
+13% +$48.4K 0.01% 48
2021
Q1
$368K Buy
5,006
+2,309
+86% +$170K 0.01% 48
2020
Q4
$210K Buy
+2,697
New +$206K 0.01% 46
2016
Q1
Sell
-24,628
Closed -$1.24M 61
2015
Q4
$1.24M Buy
+24,628
New +$1.24M 0.03% 41

Other funds holding MRK

Scharf Investments's MRK Position: Q3 2024 in Review

Scharf Investments sold out of Merck (MRK) in Q3 2024, closing a stake of 10,110 shares — an estimated $1.25M sold.

Scharf Investments first reported a position in MRK in Q4 2015 and held it in 16 quarters. The position peaked at $1.46M in Q4 2022. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Scharf Investments reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Scharf Investments sold 10,110 Merck shares in Q3 2024, an estimated $1.25M.
  • Scharf Investments first reported a position in Merck in Q4 2015 and held it in 16 quarters.
  • Scharf Investments's Merck position peaked at $1.46M in Q4 2022.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Scharf Investments's 13F filing for Q3 2024, filed 16 Oct 2024.